These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 25347737)

  • 1. The impact of osteoblastic differentiation on osteosarcomagenesis in the mouse.
    Quist T; Jin H; Zhu JF; Smith-Fry K; Capecchi MR; Jones KB
    Oncogene; 2015 Aug; 34(32):4278-84. PubMed ID: 25347737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metastatic osteosarcoma induced by inactivation of Rb and p53 in the osteoblast lineage.
    Berman SD; Calo E; Landman AS; Danielian PS; Miller ES; West JC; Fonhoue BD; Caron A; Bronson R; Bouxsein ML; Mukherjee S; Lees JA
    Proc Natl Acad Sci U S A; 2008 Aug; 105(33):11851-6. PubMed ID: 18697945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Terminal osteoblast differentiation, mediated by runx2 and p27KIP1, is disrupted in osteosarcoma.
    Thomas DM; Johnson SA; Sims NA; Trivett MK; Slavin JL; Rubin BP; Waring P; McArthur GA; Walkley CR; Holloway AJ; Diyagama D; Grim JE; Clurman BE; Bowtell DD; Lee JS; Gutierrez GM; Piscopo DM; Carty SA; Hinds PW
    J Cell Biol; 2004 Dec; 167(5):925-34. PubMed ID: 15583032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoblast differentiation and skeletal development are regulated by Mdm2-p53 signaling.
    Lengner CJ; Steinman HA; Gagnon J; Smith TW; Henderson JE; Kream BE; Stein GS; Lian JB; Jones SN
    J Cell Biol; 2006 Mar; 172(6):909-21. PubMed ID: 16533949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Runx2, p53, and pRB status as diagnostic parameters for deregulation of osteoblast growth and differentiation in a new pre-chemotherapeutic osteosarcoma cell line (OS1).
    Pereira BP; Zhou Y; Gupta A; Leong DT; Aung KZ; Ling L; Pho RW; Galindo M; Salto-Tellez M; Stein GS; Cool SM; van Wijnen AJ; Nathan SS
    J Cell Physiol; 2009 Dec; 221(3):778-88. PubMed ID: 19746444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Protein Tyrosine Phosphatase Rptpζ Suppresses Osteosarcoma Development in Trp53-Heterozygous Mice.
    Baldauf C; Jeschke A; Kanbach V; Catala-Lehnen P; Baumhoer D; Gerull H; Buhs S; Amling M; Nollau P; Harroch S; Schinke T
    PLoS One; 2015; 10(9):e0137745. PubMed ID: 26360410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conditional Deletion of Indian Hedgehog in Limb Mesenchyme Results in Complete Loss of Growth Plate Formation but Allows Mature Osteoblast Differentiation.
    Amano K; Densmore MJ; Lanske B
    J Bone Miner Res; 2015 Dec; 30(12):2262-72. PubMed ID: 26094741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling distinct osteosarcoma subtypes in vivo using Cre:lox and lineage-restricted transgenic shRNA.
    Mutsaers AJ; Ng AJ; Baker EK; Russell MR; Chalk AM; Wall M; Liddicoat BJ; Ho PW; Slavin JL; Goradia A; Martin TJ; Purton LE; Dickins RA; Walkley CR
    Bone; 2013 Jul; 55(1):166-78. PubMed ID: 23486187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The DNA helicase recql4 is required for normal osteoblast expansion and osteosarcoma formation.
    Ng AJ; Walia MK; Smeets MF; Mutsaers AJ; Sims NA; Purton LE; Walsh NC; Martin TJ; Walkley CR
    PLoS Genet; 2015 Apr; 11(4):e1005160. PubMed ID: 25859855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone environment is essential for osteosarcoma development from transformed mesenchymal stem cells.
    Rubio R; Abarrategi A; Garcia-Castro J; Martinez-Cruzado L; Suarez C; Tornin J; Santos L; Astudillo A; Colmenero I; Mulero F; Rosu-Myles M; Menendez P; Rodriguez R
    Stem Cells; 2014 May; 32(5):1136-48. PubMed ID: 24446210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histological and immunohistochemical diversities, and proliferative activity and grading in osteosarcomas.
    Hasegawa T; Hirose T; Seki K; Hizawa K; Ishii S; Wakabayashi J
    Cancer Detect Prev; 1997; 21(3):280-7. PubMed ID: 9167046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated expression of Runx2 as a key parameter in the etiology of osteosarcoma.
    Nathan SS; Pereira BP; Zhou YF; Gupta A; Dombrowski C; Soong R; Pho RW; Stein GS; Salto-Tellez M; Cool SM; van Wijnen AJ
    Mol Biol Rep; 2009 Jan; 36(1):153-8. PubMed ID: 18931939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 transactivity during in vitro osteoblast differentiation in a rat osteosarcoma cell line.
    Schwartz KA; Lanciloti NJ; Moore MK; Campione AL; Chandar N
    Mol Carcinog; 1999 Jun; 25(2):132-8. PubMed ID: 10365915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The MET oncogene transforms human primary bone-derived cells into osteosarcomas by targeting committed osteo-progenitors.
    Dani N; Olivero M; Mareschi K; van Duist MM; Miretti S; Cuvertino S; Patané S; Calogero R; Ferracini R; Scotlandi K; Fagioli F; Di Renzo MF
    J Bone Miner Res; 2012 Jun; 27(6):1322-34. PubMed ID: 22367914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional Profiling Identifies the Signaling Axes of IGF and Transforming Growth Factor-b as Involved in the Pathogenesis of Osteosarcoma.
    Yang R; Piperdi S; Zhang Y; Zhu Z; Neophytou N; Hoang BH; Mason G; Geller D; Dorfman H; Meyers PA; Healey JH; Phinney DG; Gorlick R
    Clin Orthop Relat Res; 2016 Jan; 474(1):178-89. PubMed ID: 26463566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rb1 and Pten Co-Deletion in Osteoblast Precursor Cells Causes Rapid Lipoma Formation in Mice.
    Filtz EA; Emery A; Lu H; Forster CL; Karasch C; Hallstrom TC
    PLoS One; 2015; 10(8):e0136729. PubMed ID: 26317218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WWOX and p53 Dysregulation Synergize to Drive the Development of Osteosarcoma.
    Del Mare S; Husanie H; Iancu O; Abu-Odeh M; Evangelou K; Lovat F; Volinia S; Gordon J; Amir G; Stein J; Stein GS; Croce CM; Gorgoulis V; Lian JB; Aqeilan RI
    Cancer Res; 2016 Oct; 76(20):6107-6117. PubMed ID: 27550453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of DNA replication inhibition on expression of cell growth and tissue-specific genes in osteoblasts and osteosarcoma cells.
    Kockx M; McCabe L; Stein JL; Lian JB; Stein GS
    J Cell Biochem; 1994 Jan; 54(1):47-55. PubMed ID: 8126086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of osteocalcin and its transcriptional regulators core-binding factor alpha 1 and MSX2 in osteoid-forming tumours.
    Hopyan S; Gokgoz N; Bell RS; Andrulis IL; Alman BA; Wunder JS
    J Orthop Res; 1999 Sep; 17(5):633-8. PubMed ID: 10569470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of oncogenes, tumor suppressor genes, autocrine growth-factor production, and differentiation state of human osteosarcoma cell lines.
    Isfort RJ; Cody DB; Lovell G; Doersen CJ
    Mol Carcinog; 1995 Nov; 14(3):170-8. PubMed ID: 7576109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.